Market Research Report

Global COPD and Asthma Devices Market Report By Product Type (Inhalers,Drug Powder Inhalers (DPIs),Metered Dose Inhalers (MDIs),Soft Mist Inhalers (SMIs),Nebulizers,Compressor Nebulizers ,Ultrasonic Nebulizers,Mesh Nebulizers), By Indication (Asthma,COPD), By Distribution Channel (Retail Pharmacies,Hospitals,Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11213832
January 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for COPD and Asthma Devices Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028. 

Chronic obstructive pulmonary disease (COPD) and asthma are diseases related to respiratory functions, which cause inflammation and obstruction in the airways of the lungs. Patients suffering from COPD or Asthma face difficulty in breathing and experience wheezing, frequent chest infections, and persistent chest cough. COPD and asthma devices play a vital role in the treatment of respiratory diseases. These devices offer long-lasting treatment and therapy for COPD, Asthma, and other related respiratory diseases. COPD and asthma devices include inhalers, nebulizers, peak flow meter, and others.

Market Dyanamics

The global COPD and asthma devices market is experiencing a surge owing to the increasing prevalence of respiratory diseases and growing environmental pollution. The increasing need for rescue medication during a sudden asthma attack or breathlessness and increasing preference for efficient but short term medication are the factors that are propelling the market. On-going pandemic COVID-19 has similar symptoms as COPD and Asthma. To give quick treatment to the COVID patients facing shortness in breathing, demand for COPD and Asthma devices is rising. Moreover, factors such as advancement in technology, the introduction of portable devices by key manufacturers, and growing government funding are fuelling the market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of copd and asthma devices.

Market Segmentation

This section of the copd and asthma devices market report  provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Product Type
  • Inhalers
  • Drug Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers (SMIs)
  • Nebulizers
  • Compressor Nebulizers 
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

By Indication
  • Asthma
  • COPD

By Distribution Channel
  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for COPD and Asthma Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global COPD and Asthma Devices Market Share by Region (Representative Graph)

Global COPD and Asthma Devices Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the copd and asthma devices market include Aerogen, Inc., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, 3M COMPANY, GF Health Products, GlaxoSmithKline Plc, Koninklijke Philips N.V., Novartis AG, PARI medical Holding GMBH, and Smith’s Group Plc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . COPD AND ASTHMA DEVICES – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product Type
           3.7.2 By Indication
           3.7.3 By Distribution Channel
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL COPD AND ASTHMA DEVICES MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Product Type
       6.4 Inhalers Market by Regions
       6.6 Drug Powder Inhalers (DPIs) Market by Regions
       6.5 Metered Dose Inhalers (MDIs) Market by Regions
       6.7 Soft Mist Inhalers (SMIs) Market by Regions
       6.8 Nebulizers Market by Regions
       6.9 Compressor Nebulizers  Market by Regions
       6.10. Ultrasonic Nebulizers Market by Regions
       6.11 Mesh Nebulizers Market by Regions
 
7 . GLOBAL COPD AND ASTHMA DEVICES MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical and Forecast Data
       7.3 Analysis by Indication
       7.4 Asthma Market by Regions
       7.5 COPD Market by Regions
 
8 . GLOBAL COPD AND ASTHMA DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Historical and Forecast Data
       8.3 Analysis by Distribution Channel
       8.4 Retail Pharmacies Market by Regions
       8.5 Hospitals Market by Regions
       8.6 Online Pharmacies Market by Regions
 
9 . GLOBAL COPD AND ASTHMA DEVICES MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE COPD AND ASTHMA DEVICES COMPANIES
       10.1. Copd And Asthma Devices Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF COPD AND ASTHMA DEVICES INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Aerogen, Inc.
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. AstraZeneca PLC
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Baxter International Inc.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Boehringer Ingelheim International GmbH
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. 3M Company
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. GF Health Products
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. GlaxoSmithKline Plc
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Koninklijke Philips N.V.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Novartis AG
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. PARI Medical Holding GMBH
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Smith’s Group Plc
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Inhalers Market by Geography (USD MN)
  • Drug Powder Inhalers (DPIs) Market by Geography (USD MN)
  • Metered Dose Inhalers (MDIs) Market by Geography (USD MN)
  • Soft Mist Inhalers (SMIs) Market by Geography (USD MN)
  • Nebulizers Market by Geography (USD MN)
  • Compressor Nebulizers  Market by Geography (USD MN)
  • Ultrasonic Nebulizers Market by Geography (USD MN)
  • Mesh Nebulizers Market by Geography (USD MN)
  • Analysis Market by Indication (USD MN)
  • Asthma Market by Geography (USD MN)
  • COPD Market by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Online Pharmacies Market by Geography (USD MN)
  • Global Copd And Asthma Devices Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Copd And Asthma Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Copd And Asthma Devices Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Segment Analysis 1 (USD MN)
  • Inhalers Market by Geography (USD MN)
  • Drug Powder Inhalers (DPIs) Market by Geography (USD MN)
  • Metered Dose Inhalers (MDIs) Market by Geography (USD MN)
  • Soft Mist Inhalers (SMIs) Market by Geography (USD MN)
  • Nebulizers Market by Geography (USD MN)
  • Compressor Nebulizers  Market by Geography (USD MN)
  • Ultrasonic Nebulizers Market by Geography (USD MN)
  • Mesh Nebulizers Market by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Asthma Market by Geography (USD MN)
  • COPD Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Online Pharmacies Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials